Preimplantation embryos are vulnerable to various cellular stresses when grown in an *in vitro* environment \[[@r1]\]. *In vitro* embryo production requires a culture medium of *in vitro* environment similar to that of the oviduct and uterine tube \[[@r2]\]. Embryos in an *in vivo* environment can resist oxidative stress through antioxidants that are present in the follicular fluid \[[@r3]\], or produced by the embryos themselves and the oviduct \[[@r4]\]. *In vitro* culture is performed to produce embryos for the establishment of animal and disease models \[[@r5]\]. However, developmental anomalies are major obstacles in the production of high-quality *in vitro*-produced embryos \[[@r6]\]. The coupling of reactive oxygen species (ROS) and endoplasmic reticulum (ER) stress initiation negatively affects *in vitro* cultures \[[@r7]\]. In eukaryotes, the ER plays a major role in protein structural modification; however, unfolded protein accumulation in the ER lumen triggers ER stress, which leads to cellular damage and apoptosis \[[@r8], [@r9]\].

Preimplantation embryo development requires a transition from maternal to embryonic RNA, which requires extensive new protein synthesis \[[@r10]\]. These new proteins must be folded properly in the ER lumen to maintain preimplantation embryo development. The ER is the first compartment in the secretory pathway in eukaryotic cells. This organelle is responsible for the synthesis of proteins and their modification and delivery to target sites within the secretory pathway and the extracellular spaces \[[@r11]\]. Secretory proteins enter the secretory pathway through the ER. Apart from protein folding, the ER also participates in helping proteins achieve correct conformation during post-transitional modifications \[[@r12]\]. Furthermore, the ER is a major intracellular organelle responsible for Ca^2+^ homeostasis \[[@r13]\] and plays an important role in the structural modification of proteins via balanced Ca^2+^ signaling \[[@r11]\]. However, under pathological conditions, the accumulation of misfolded proteins in the ER lumen leads to ER stress \[[@r8]\], which ultimately leads to cellular damage and apoptosis \[[@r9], [@r14]\].

Reduced glutathione (GSH) is an antioxidant composed of three amino acids, namely, glutamate, cysteine, and glycine. GSH serves as an antioxidant, a cellular protectant, a regulatory signaling molecule, and also maintains intracellular redox state \[[@r15], [@r16]\]. GSH protects the cells from toxicants and ROS \[[@r17]\]. Due to its high cellular abundance and low redox potential, GSH is utilized as a redox buffer for reducing oxidized cysteine residues, providing protection against irreversible oxidation, and scavenging various endogenous and exogenous electrophilic compounds \[[@r18]\]. GSH plays a major role in the formation of oocytes, fertilization, and initiation of embryo development \[[@r19], [@r20]\]. Decreased GSH concentration before *in vitro* fertilization prevents pronuclear formation and arrests embryonic development \[[@r21]\]. During the development of bovine embryos, inhibition of GSH synthesis reduces development at the eight-cell and blastocyst stages \[[@r22]\], whereas GSH supplementation in the *in vitro* culture medium promotes pronuclear formation \[[@r23]\]. GSH is involved in multiple molecular processes, such as enzyme activation, protein folding, cellular proliferation, differentiation, and apoptosis \[[@r24]\]. Moreover, GSH is a free thiol compound involved in cellular protection, amino acid transport, and DNA and protein synthesis \[[@r25]\]. GSH plays a major role in the refolding of misfolded proteins by converting non-native disulfide bonds into native disulfide bonds \[[@r26]\]. However, tunicamycin (TM) inhibits N-linked glycosylation in newly synthesized polypeptides and elicits ER stress \[[@r27]\]. TM supplementation in the culture medium negatively affects embryonic development by inducing ER stress \[[@r28], [@r29]\]. In the current study, we investigated the effects of GSH on TM-induced ER stress. To the best of our knowledge, this study is the first to elucidate the effect of GSH on ER stress during *in vitro* mouse preimplantation embryo.

Materials and Methods {#s1}
=====================

Animal ethics statement
-----------------------

Healthy 8--10-week-old male and female Kunming mice (*Mus musculus*), an outbred mouse strain originating from the Swiss albino mouse \[[@r30]\], were purchased from the Experimental Animal Center of Yanbian University. All mice were housed during the experimental study in a 12:12 h light/dark cycle at approximately 24°C. The experimental procedure was approved by the Institutional Animal Care and Use Committee of Yanbian University.

Chemicals and reagents
----------------------

All chemicals and reagents used in this study were purchased from Sigma-Aldrich (St. Louis, MO, USA), unless otherwise indicated.

Superovulation, embryo collection, and culture
----------------------------------------------

Each female mouse first received an intraperitoneal injection of 10 IU pregnant mare serum gonadotropin (Ninbo Hormone Product, China; Catalog Number 140825), and then 10 IU human chorionic gonadotropin (hCG; Ninbo Hormone Product, China; Catalog Number 140913) 48 h later. Immediately after hCG administration, each female mouse was mated with one male mouse and checked for vaginal plugs 12 h later. After 22 h of hCG injection, the mice with plugs were sacrificed.

Their oviducts were extracted and placed in M2 medium (M7167; Sigma-Aldrich). Zygotes were released from the oviducts as observed under a stereo microscope. Cumulus cells were removed with 0.03% hyalunronidase (H3506; Sigma-Aldrich), and the zygotes were then washed with fresh M2 medium. Different concentrations (0.5, 1, and 1.5 mM) of GSH were used. For this purpose, a stock solution (100 mM) of GSH was prepared by dissolving 0.0307 g of reduced GSH in 1 ml M16 medium. For the above-mentioned concentrations, 5 μl (0.5 mM), 10 μl (1 mM), and 15 μl (1.5 mM) of this solution was added to 995 μl, 990 μl, and 985 μl of M16 medium, respectively. The zygotes were divided into four groups (n = 12 each) for further analyses. The zygotes in the first group were cultured in 35-µl drops of M16 medium (M7292; Sigma-Aldrich). The zygotes in the second, third, and fourth groups were cultured in 35-µl drops of M16 medium containing 0.5 µg/ml TM, 0.5 µg/ml TM plus 1 mM GSH, and 1 mM GSH covered with mineral oil, respectively. All embryos were incubated at 37°C under a water-saturated atmosphere of 5% CO~2~. Embryonic development was observed every 24 h. Each experiment was repeated at least three times.

Measurement of ROS content
--------------------------

Twenty blastocysts and four-cell embryos from each group were washed twice in poly vinyl alcohol- phosphate buffered saline PVA-PBS (1 mg/ml), placed in 50-µl droplets of 10 µM 2,7-dichlorodihydro-fluoroscein diacetate (DCFH-DA) (D6883; Sigma-Aldrich), and then incubated at 37°C in an atmosphere of 5% CO~2~ for 15 min. After incubation, the embryos were washed three times in PVA-PBS and then observed under a fluorescent microscope (1X71; Olympus, Tokyo, Japan). The fluorescence of each blastocyst was measured and analyzed with Image-Pro Plus 6.0 software (Media Cybernetics, Rockville, MD, USA). All images were captured under same conditions. The excitation wavelength was 480 nm and the emission wavelength was 510 nm. The results are shown as the relative intensity of fluorescence.

Assessment of intracellular GSH level
-------------------------------------

Mouse embryos were assessed for intracellular GSH level on day 4 using 10 µM Cell Tracker Blue 4-chloromethyl-6,8-difluoro-7-hydroxycoumarin (CMF2HC; Catalog Number C12881, Life Technologies Corporation Carlsbad USA). The embryos were washed with PVA-PBS and then observed under a fluorescent microscope (1X71; Olympus). The fluorescence of each blastocyst was measured and analyzed with Image-Pro Plus 6.0 (Media Cybernetics). All images were captured under the same conditions. The excitation wavelength was 371 nm and the emission wavelength was 464 nm. The results are shown as the relative intensity of fluorescence.

TUNEL assay
-----------

The apoptotic blastomeres in blastocysts were evaluated by performing TUNEL assay using an cell death detection kit (Calbiochem Roche Diagnostics, San Diego USA; Catalog Number QIA 39). The blastocysts (n = 30) were briefly fixed, washed them three times in 4% paraformaldehyde (PFA; pH 7.4), and then fixed in 4% PFA for 1 h at 30°C. The fixed blastocysts were washed in tris buffered saline (TBS) and then permeabilized by incubation in 0.5% Triton X-100 for 1 h. The blastocysts were washed three times in TBS and then placed in 1 × terminal deoxynucleotidyl transferase (1 × TdT) for 20 min at 30°C. After 20 min, the blastocysts were transferred to 50 µl of TdT labeling reaction mixture (57 µl of fluorescin-Frag FL TdT labeling reaction + 3 µl TdT enzyme) and then incubated for 1 h. After washing three times, the blastocysts were mounted on a microscope slide in a drop of fluorescent media, and then pressed gently with a glass cover slip. The blastocysts were observed immediately using a Nikon microscope (ECLIPSE Ti-S 634268 Nikon, Melville, USA) at 400 × magnification. Photographs were taken with 1600 ASA color film. The excitation wavelength was 380 nm and the emission wavelength was 495 nm. The apoptotic cells appeared green. The results are shown as the relative intensity of fluorescence.

RNA isolation and cDNA synthesis
--------------------------------

Three biological replicates, each containing 100 blastocysts from each group, were used for RNA isolation. Total RNA was isolated from whole embryos by using Qiagen RNeasy Mini Kit (Qiagen, Hilden, Germany; Catalog Number 74104) in accordance with the manufacturer's instructions. RNA concentration and purity were measured as previously described \[[@r31]\]. cDNA was synthesized using the Prime Script™ RT Reagent Kit (Takara Biotechnology, Dalian, China; Catalog Number RR036A).

Semi quantitative real-time polymerase chain reaction (RT-PCR)
--------------------------------------------------------------

Primer sequences and annealing temperatures are listed in [Table 1](#tbl_001){ref-type="table"}Table 1.Information on the primers used for amplificationGeneAccess NumberSequenceTmperrature\
(°C)Length\
(bp)*BIP*NM_001163434forward, 5'ACTTGGGGACCACCTATTCCT-3'59134reverse, 5'ATCGCCAATCAGACGCTCC-3'*PERK*NM_010121forward, 5'GGGAAAACGGTTCTGAGACA-3'59332reverse, 5'GCTGACCAGCTAGTCTTGGG-3'*ATF4*NM_009716forward, 5'TCGATGCTCTGTTTCGAATG-3'59312reverse, 5'AAGCAGCAGAGTCAGGCTTC-3'*ATF6*NM_001081304forward, 5'TGGGCAGGACTATGAAGTAATG-3'62190reverse, 5'CAACGACTCAGGGATGGTGCTG-3'*CHOP*NM_007837forward, 5'ACAGAGGTCACACGCACATC-3'62336reverse, 5'CTTCCGGAGAGACAGACAGG-3'*BAX*NM_007527forward, 5'CCAGGATGCGTCCACCAA-3'60195reverse, 5'AAGTAGAAGAGGGCAACCAC-3'*BCL2*NM_007527forward, 5'ACCTCTTCAGGGATGGGG-3'60144reverse, 5'GCCGGTTCAGGTACTCAG-3'*GAPDH*BC023196forward, 5'CATCACCATCTTCCAGGAGCG-3'59357reverse, 5'GAGGGGCCATCCACAGTCTTC-3'. PCR was performed in 25-µl reaction volume containing 13 µl of 2 × Taq PCR Master Mix (Tiangen Biotech, Beijing, China; Catalog Number KT201), 4 µl of cDNA, 6 µl of H~2~O, and 1 µl of forward and reverse primers. The PCR program was as follows: initial pre-incubation at 95°C for 3 min; 35 cycles of denaturation at 95°C for 30 sec, annealing at 59--62°C for 30 sec, and extension at 72°C for 30 sec; and a final extension at 72°C for 5 min. The PCR products were separated by gel-electrophoresis on 2% agarose gels containing ethidium bromide, and then visualized under UV illumination \[[@r32]\].

Statistical analysis
--------------------

All assays were performed on three separate occasions. All comparisons for parametric data were performed using multiple comparisons in SPSS 17.0 and one-way analysis of variance (ANOVA) followed by post-hoc Turkey's multiple comparison test using GraphPad Prism 5 software (La Jolla, CA, USA). Statistical significance was considered at P \< 0.05.

Results {#s2}
=======

Effect of TM and GSH on the developmental ability of preimplantation embryos
----------------------------------------------------------------------------

TM was initially used alone to induce stress; then, TM and GSH were used in combination and their effect on ER stress and embryo developmental competence was observed ([Table 2](#tbl_002){ref-type="table"}Table 2.Effect of tunicamycin and GSH on the developmental potential of preimplantation embryosTreated groupZygote No2 Cell4 Cell8 CellBlastocystControl18592.50 ± 3.27 ^a^82.00 ± 5.83 ^a^70.50 ± 3.53 ^a^50.00 ± 3.16 ^a^TM17087.00 ± 4.16 ^a^74.50 ± 5.74 ^a^36.00 ± 3.14 ^b^18.50 ± 1.30 ^b^TM +GSH17194.00 ± 3.14 ^a^85.00 ± 5.00 ^a^72.50 ± 3.74 ^a^53.50 ± 3.50 ^a^Control+GSH18097.50 ± 1.70 ^a^86.50 ± 3.80 ^a^82.00 ± 3.95 ^c^69.50 ± 4.91 ^c^Data are the proportions of zygotes reaching the indicated stages within each treatment. Data are expressed as a mean value ± standard error of the mean (SEM) of three independent experiments. Different letters in the same column mean significant difference between the treatments (P \< 0.05).). The optimum dose of TM and GSH were used as mention in [Tables 3](#tbl_003){ref-type="table"} and[4](#tbl_004){ref-type="table"}Table 3.Effect of different concentrations of tunicamycin on the developmental potential of mouse embryos *in vitro*Treated groupZygote No2 Cell4 Cell8 CellBlastocystControl18592.50 ± 3.27 ^a^82.00 ± 5.83 ^a^70.50 ± 3.53 ^a^50.00 ± 3.16 ^a^TM (0.25)19090.00 ± 2.58 ^a^78.50 ± 3.16 ^a^65.50 ± 2.73 ^a^44.50 ± 3.90 ^a^TM (0.5)17087.00 ± 4.16 ^a^74.50 ± 5.74 ^a^36.00 ± 3.14 ^b^18.50 ± 1.30 ^b^TM (0.75)18085.50 ± 3.20 ^a^73.00 ± 2.80 ^a^26.00 ± 3.39 ^c^10.00 ± 2.23 ^c^Data are the proportions of zygotes reaching the indicated stages within each treatment. Data are expressed as a mean value ± standard error of the mean (SEM) of three independent experiments. Different letters in the same column mean significant difference between the treatments (P \< 0.05).Table 4.Effect of different concentrations of GSH on the developmental potential of mouse embryos *in vitro*Treated groupZygote No2 Cell4 Cell8 CellBlastocystControl18592.50 ± 3.27 ^a^82.00 ± 5.83 ^a^70.50 ± 3.53 ^a^50.00 ± 3.16 ^a^TM17087.00 ± 4.16 ^a^74.50 ± 5.74 ^a^36.00 ± 3.14 ^b^18.50 ± 1.30 ^b^TM + 0.5 mM GSH18190.00 ± 3.16 ^a^81.00 ± 3.85 ^a^50.50 ± 3.83 ^c^32.00 ± 4.66 ^c^TM + 1 mM GSH17194.00 ± 3.14 ^a^85.00 ± 5.00 ^a^72.50 ± 3.74 ^a^53.50 ± 3.50 ^a^TM + 1.5 mM GSH17095.00 ± 2.58 ^a^87.00 ± 3.43 ^a^75.00 ± 4.15 ^a^56.00 ± 5.51 ^a^Data are the proportions of zygotes reaching the indicated stages within each treatment. Data are expressed as a mean value ± standard error of the mean (SEM) of three independent experiments. Different letters in the same column mean significant difference between the treatments (P \< 0.05)., respectively. No significant difference in the two- and four-cell stages was observed between the groups (TM alone, or in combination with GSH). However, the proportion of embryos reaching the eight-cell stage was significantly lower after exposure to 0.5 µg/ml TM than after exposure to 0.5 µg/ml TM + 1 mM GSH or control treatment or 1 mM GSH alone (36.00 ± 3.14 *vs*. 72.50 ± 3.74 *vs*. 70.50 ± 3.53 and 82.00 ± 3.95, respectively). Meanwhile, a higher blastocyst rate was found in the embryos treated with control or 0.5 µg/ml TM + 1 mM GSH or 1 mM GSH alone than those treated with TM (50.00 ± 3.16 *vs*. 53.50 ± 3.50 *vs*. 69.5 ± 4.91 and 18.50 ± 1.30, respectively). [Table 2](#tbl_002){ref-type="table"} shows the beneficial effects of GSH on embryonic development in the presence of TM.

Effect of TM and GSH on internal ROS level
------------------------------------------

As shown in [Table 2](#tbl_002){ref-type="table"}, GSH influenced embryonic development at the blastocyst stage. We investigated whether this effect was due to reduced ROS production. We assessed the ROS level at the four-cell and blastocyst stages. Our results showed no significant difference in ROS levels at the four-cell stage between the different groups ([Figs. 1](#fig_001){ref-type="fig"}A and[1](#fig_001){ref-type="fig"}BFig. 1.Evaluation of ROS content in embryos at 4-cell stage in different culture media (control = C, tunicamycin = T, and tunicamycin + GSH = TG) by staining with DCFH-DA. (A) Fluorescence microscopy of embryos cultured in different media. (B) Quantification of ROS levels in the indicated groups. Fluorescence intensity analysis demonstrates no significant difference in ROS level at the 4-cell stage between the different groups. Images are presented at 400 × magnification. Data are expressed as mean ± standard error of the mean (SEM) of three independent experiments. Asterisks represent statistically significant differences (P \< 0.05).). However, ROS level at the blastocyst stage was significantly higher in the group supplemented with 0.5 µg/ml TM as compared with the control group, whereas addition of 1 mM GSH significantly decreased ROS level ([Figs. 2](#fig_002){ref-type="fig"}A and[2](#fig_002){ref-type="fig"}BFig. 2.Evaluation of ROS content in embryos at blastocyst stage in different culture media (control = C, tunicamycin = T, and tunicamycin + GSH = TG) by staining with DCFH-DA. (A) Fluorescence microscopy of embryos cultured in different media. (B) Quantification of ROS levels in the indicated groups. Fluorescence intensity analysis demonstrates a higher significance (P \< 0.05) for blastocyst-stage embryo exposed to TM. Images are presented at 400 × magnification. Data are expressed as mean ± SEM of three independent experiments. Asterisks represent statistically significant differences (P \< 0.05).).

Effect of TM and/or reduced GSH on intracellular GSH level
----------------------------------------------------------

As shown in [Table 2](#tbl_002){ref-type="table"} and [Fig. 3](#fig_003){ref-type="fig"}Fig. 3.Evaluation of GSH content in embryos at blastocyst stage in different culture media (control = C, tunicamycin = T, and tunicamycin + GSH = TG) by staining with CMF2HC (A) Fluorescence microscopy of embryos cultured in different media. (B) Quantification of GSH levels in the indicated groups. Fluorescence intensity analysis demonstrates a higher significance (P \< 0.05) for blastocyst-stage embryo exposed to TM. Images are presented at 400 × magnification. Data are expressed as mean ± SEM of three independent experiments. Asterisks represent statistically significant differences (P \< 0.05)., TM negatively affected the embryos, and GSH reversed the negative effects of TM. Further investigation showed that TM significantly decreased the level of intracellular GSH ([Figs. 3](#fig_003){ref-type="fig"}A and[3](#fig_003){ref-type="fig"}B).

Effect of GSH on the quality of blastocysts in in vitro environment
-------------------------------------------------------------------

We investigated whether GSH only reduces ROS level or also affects the quality of blastocysts in *in vitro* environment. TUNEL assay was performed to determine the apoptotic index in the various treatment groups. Mouse embryos were cultured in a medium supplemented with TM, the ER stress inducer, or GSH, the ER stress inhibitor. Embryos cultured in medium without any supplementation served as the control group. The results of TUNEL assay showed that blastocysts in the TM group underwent apoptosis and possessed lower total cell number compared with those in the control and GSH groups ([Figs. 4](#fig_004){ref-type="fig"}A and[4](#fig_004){ref-type="fig"}BFig. 4.Effect of tunicamycin and/or GSH on apoptosis in mouse preimplantation embryos. (A) Apoptotic cells in the mouse blastocyst were evaluated by TUNEL assay in different treatment groups (control = C, tunicamycin = T, and tunicamycin + GSH = TG) counterstained with DAP1. (B) The total cell numbers, apoptotic blastomeres, and apoptotic index. Apoptotic index = apoptotic cell/total cell in a blastocyst. Data are expressed as mean ± SEM of three independent experiments. Asterisks represent statistically significant differences (P \< 0.05).).

Effect of GSH on ATF6 localization in mouse preimplantation embryos
-------------------------------------------------------------------

Considering that GSH benefits embryonic development by alleviating ROS generation, we further investigated whether this effect may involve ER stress pathways during unfolded protein response (UPR). The glucose regulatory protein, immunoglobulin-binding protein (*BiP*), has been used as an indicator of the onset of ER stress \[[@r33]\]. During ER stress, activating transcription factor 6 (*ATF6*) dissociates from *BiP*, and the activated form of *ATF6* upregulates C/EBP homologous protein (*CHOP*) expression \[[@r33]\]. Thus, we determined whether GSH affects the *BiP-ATF6* pathway in mouse preimplantation embryos. Results showed that the expression levels of *BiP* and *ATF6* were significantly reduced in the GSH group as compared with the TM group ([Figs. 5](#fig_005){ref-type="fig"}A and[5](#fig_005){ref-type="fig"}BFig. 5.The expression of *BiP* and *ATF6* in mouse embryos cultured in different media (control = C, tunicamycin = T, and tunicamycin + GSH = TG). *GAPDH* was used as an internal control. (A) PCR results of *BiP* and *ATF6* in mouse embryos. (B) Relative expression of *BiP* and *ATF6* normalized with the internal marker *GAPDH* (P \< 0.05). Data are expressed as mean ± SEM of three independent experiments. Asterisks represent statistically significant differences (P \< 0.05).). This result suggests that GSH significantly reduces TM-induced ER stress.

Effect of GSH on the expression of protein kinase-like ER kinase (PERK) pathway-related genes
---------------------------------------------------------------------------------------------

We evaluated the expression of *PERK*, which plays a key role in ER stress, to further investigate the ER stress response pathways. *PERK* is released from *BiP* during ER stress and then activates activating transcription factor 4 (*ATF4*)*,* leading to the upregulation of *CHOP* expression \[[@r34], [@r35]\]. Thus, we determined whether GSH affects the *PERK-ATF4-CHOP* pathway. Real-time polymerase chain reaction (RT-PCR) analysis demonstrated that *PERK* expression was significantly downregulated in the GSH group as compared with the TM group. In addition, co-treatment with GSH significantly reduced the expression of *ATF4* and *CHOP* as compared with TM group ([Figs. 6](#fig_006){ref-type="fig"}A and[6](#fig_006){ref-type="fig"}BFig. 6.The expression of *PERK*, *ATF4*, and *CHOP* in mouse embryos cultured in different media (control = C, tunicamycin = T, and tunicamycin + GSH = TG). *GAPDH* was used as an internal control. (A) PCR results of *PERK*, *ATF4*, and *CHOP* expression in mouse embryos. (B) Relative expression of *PERK*, *ATF4*, and *CHOP* normalized with the internal marker *GAPDH* (P \< 0.05). Data are expressed as mean ± SEM of three independent experiments. Asterisks represent statistically significant differences (P \< 0.05).). Hence, these results confirm that GSH alleviates ER stress.

Effect of GSH on blastocyst apoptosis
-------------------------------------

The rate of apoptosis is determined by DNA fragmentation in blastomeres, which occurs during preimplantation embryonic development under stress conditions \[[@r36]\]. Thus, we investigated whether GSH is involved in the prevention of ER stress-induced apoptosis. The expression levels of anti- and pro-apoptotic genes, including B cell lymphoma 2 (*BCL2*) and B cell-associated X protein (*BAX*), in blastocysts cultured in the presence and absence of GSH were measured using RT-PCR. The RNA expression of *BCL2* significantly increased, whereas that of *BAX* significantly decreased in blastocysts grown with 1 mM GSH compared to that in blastocysts grown with 0.5 µg/ml TM ([Figs. 7](#fig_007){ref-type="fig"}A and[7](#fig_007){ref-type="fig"}BFig. 7.The expression of *BAX* and *BCL2* in mouse embryos cultured in different media (control = C, tunicamycin = T, and tunicamycin + GSH = TG). *GAPDH* was used as an internal control. (A) PCR results of *BAX* and *BCL2* expression in mouse embryos. (B) Relative expression of *BAX* and *BCL2* normalized with the internal marker *GAPDH* (P \< 0.05). Data are expressed as mean ± SEM of three independent experiments. Asterisks represent statistically significant differences (P \< 0.05).). These findings indicate that GSH significantly reduces TM-induced apoptosis.

Discussion {#s3}
==========

To the best of our knowledge, this study is the first to demonstrate GSH as an ER stress inhibitor in mouse preimplantation embryo development. GSH reduces oxidative stress and enhances embryonic development \[[@r4], [@r23]\]. Exposure of embryos to *in vitro* environment can cause developmental defects \[[@r37]\] due to several types of stresses, such as growth and survival factors, deprivation, metabolic and substrate imbalance, and oxidative and osmotic stress \[[@r38]\]. In addition, ER stress plays an important role in embryonic development \[[@r13]\]. In the ER, UPR is an adaptive mechanism that attempts to restore the balance between newly synthesized unfolded protein and folding capacity. Various physiological stress conditions may interrupt protein folding and induce protein misfolding, ultimately leading to ER stress and triggering apoptosis during *in vitro* embryo development \[[@r13], [@r39], [@r40]\].

GSH reduces ROS and oxidative stress during embryo development \[[@r41]\]. Exposure of cleavage-stage embryos to low GSH concentration reduces embryo development from the two-cell to the blastocyst stage \[[@r42], [@r43]\]. However, the precise functional role of GSH as an ER stress inhibitor in preimplantation embryos is unclear. We hypothesized that GSH plays a similar role in the protection of preimplantation embryos against ER stress. Embryos were developed in ER stress environment with 0.5 µg/ml TM as a stress inducer. TM inhibits protein synthesis at the N-linked glycosylation step in the ER \[[@r27]\]. TM significantly reduced the developmental potential of embryos at the eight-cell and blastocyst stages. Co-treatment with TM and 1 mM GSH significantly increased the developmental potential of embryos at the eight-cell and blastocyst stages. Similarly, previous studies have shown that TM reduces mouse embryo development at the blastocyst stage, while the ER stress inhibitor tauroursdexoycholate (TUDCA) enhances this process \[[@r44]\]. Furthermore, GSH supplementation increases the blastocyst rate during embryonic development with increasing O~2~ concentration \[[@r7]\]. GSH assists in protein refolding and reduces the misfolded proteins in the ER lumen by converting non-native disulfide bonds into disulfide bonds \[[@r26]\]. TUDCA is a bile acid that acts as a potent chemical chaperon inhibiting apoptosis associated with ER stress; it enhances the maturation of oocytes and the development of preimplantation embryos by activating the mitogen-activated protein kinase pathway \[[@r45]\].

To further explore the relationship between ER stress and ROS level, we detected the ROS level at the blastocyst stage by using DCFH-DA fluorescence. Results revealed that ROS levels were significantly increased in embryos exposed to TM; however, GSH treatment significantly reduced the ROS levels in these embryos. Our findings are in line with those from previous work by Yoon *et al*. \[[@r7]\], who reported that ROS level is increased with increasing O~2~ concentration, while GSH decreases the ROS level in bovine embryos.

GSH plays a critical role in regulating intracellular redox balance and protecting cells against ROS \[[@r46]\]. In the present study, we examined the effect of ER stress on intracellular GSH levels in mouse embryos. Results showed that ER stress reduced intracellular GSH levels, whereas 1 mM GSH increased the levels significantly by inhibiting ER stress ([Fig. 3](#fig_003){ref-type="fig"}). Our results are supported by the findings of Lin *et al*. \[[@r28]\], who reported that TM reduces intracellular GSH levels in porcine embryos, while co-treatment with TUDCA increases its levels.

The TUNEL assay is useful in exploring the quality and viability of blastocysts produced under i*n vitro* conditions \[[@r47], [@r48]\]. Using this method, we analyzed the quality of blastocysts after TM and GSH treatment. Compared with those treated with GSH, blastocysts treated with GSH showed higher expansion level, greater total cell number, and lesser apoptotic cell number. Our results are similar to the findings of Sharma *et al*., who reported that TM increases the apoptotic index and decreases the total cell number, while TUDCA enhances the total cell number and decreases the apoptotic index in bovine embryos \[[@r29]\]. Yoon *et al*. \[[@r7]\] reported that GSH reduces the number of apoptotic cells in the blastocysts during bovine early embryonic development under oxidative stress conditions. In porcine embryo development, TUDCA increases the level of expansion and the number of total cells and decreases the number of apoptotic cells compared with TM.

*BiP* regulates ER stress; under physiological conditions, binding of *BiP* to the luminal domain of *ATF6* in the ER maintains it in an inactive form. However, upon induction of ER stress, *BiP* dissociates from *ATF6* and activates *ATF6* \[[@r50]\]. In the present study, the expression levels of *BiP* and *ATF6* were increased in embryos treated with TM, whereas GSH supplementation significantly downregulated the expression of *BiP* and *ATF6*. Similarly, Murat *et al*. \[[@r44]\] reported that TM enhances the expression of *BiP*, which negatively affects embryonic development. TUDCA supplementation significantly downregulates the expression of *BiP* in mouse embryos. Rapamycin downregulates the expression of *BiP* and *ATF6* in mouse preimplantation embryos, whereas ER stress inducers upregulate their expression \[[@r51]\]. In bovine somatic cells nuclear transfer embryos, valproic acid downregulates the expression of *BiP* and improves embryonic development \[[@r52]\].

*PERK* is an ER transmembrane sensor present in the ER lumen and attached to *BiP*. In ER stress conditions, dimerization of *PERK* leads to its release from *BiP*, and trans-autophosphorylation leads to activation of eukaryotic translational initiation factor 2 alpha kinase \[[@r53]\]. *PERK* induces the UPR-dependent gene transcription \[[@r54]\]. *ATF4* is a transcription factor whose translation is initiated upon *PERK*-mediated phosphorylation. Phosphorylated *PERK* and *ATF4* are required for inducing apoptosis-inducing factors, such as *CHOP* \[[@r55]\]. *CHOP* participates in the ER stress-induced apoptosis pathway and promotes apoptosis under severe ER stress conditions \[[@r33]\]. In the present study, TM treatment significantly upregulated the gene expression of *PERK*, *ATF4*, and *CHOP*, whereas GSH supplementation significantly reduced their expression. Similarly, Yoon *et al*. found that in bovine embryos, increased oxygen concentrations enhance the expression of the above genes, while TUDCA suppresses it \[[@r7]\]. During ER stress *ATF4* is activated, and treatment with histone deacetylase 4 inhibits *ATF4* activation and protects the cells from ER stress-induced apoptosis \[[@r56]\]. Rapamycin improves mouse embryonic development by downregulating the expression of *PERK*, *ATF4*, and *CHOP* \[[@r51]\].

ER stress can induce apoptosis \[[@r31]\]. Our results suggest that GSH also plays an important role in protecting mouse embryos against ER stress-induced apoptosis. To investigate the mechanism through which GSH protects mouse embryos against ER stress-induced apoptosis, we examined the expression levels of the pro-apoptotic gene *BAX* and the anti-apoptotic gene *BCL2*. *BAX* is a member of the pro-apoptotic gene family, whereas *BCL2* is a prominent inhibitor of apoptosis \[[@r54]\]. We measured the expression levels of *BAX* and *BCL2* after TM and GSH treatments. TM decreased the expression of *BCL2*, but increased that of *BAX*. GSH supplementation significantly increased the expression of *BCL2*, but decreased that of *BAX*. Our results are supported by the findings of Zhang *et al*. \[[@r45]\], who reported that TM as an ER stress inducer increases the expression of *BAX* and decreases that of *BCL2*, while co-treatment with TUDCA significantly downregulates *BAX* and upregulates *BCL2* expression in mouse embryos. TM increases the expression of *BAX* and decreases that of *BCL2*, whereas TUDCA treatment decreases the expression of *BAX* and upregulates that of *BCL2* in bovine embryos \[[@r29]\].

In conclusion, GSH plays a major role in the development of preimplantation mouse embryos under ER stress conditions. TM-induced ER stress causes the arrest of embryo development at the eight-cell and blastocyst stages. GSH supplementation in the medium increases embryo development, decreases the number of apoptotic cells, downregulates pro-apoptotic and ER stress-related gene expression, and upregulates anti-apoptotic gene expression.
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